CCI Approves Strides Shasun’ Acquisition Plan - 13.01.2016

Competition Commission of India (CCI) has approved Strides Shasun’ plan to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.

Tags : Competition Commission of India (CCI) Strides Shasun Sun Pharmaceutical

Share :